The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12721830 B1

Date of Patent:

Sep. 01, 2026

Filed:

Sep. 04, 2025

Compositions comprising selective androgen receptor modulator compounds in combination with weight loss drugs and uses thereof for quality weight loss

Applicant:

Veru Inc., Miami, FL (US);

Inventors:

Mitchell S. Steiner, Germantown, TN (US);

Kester Gary Barnette, Denver, NC (US);

Assignee:

VERU INC., Miami, FL (US);

Attorneys:

Mark S. Cohen

PEARL COHEN LLP

Primary Examiner:

Rayna Rodriguez

Int. Cl.

CPC ...

A61K 31/277 (2006.01); A61K 38/26 (2006.01); A61P 3/04 (2006.01); A61P 21/00 (2006.01); A61P 21/06 (2006.01);

U.S. Cl.

CPC ...

A61K 31/277 (2013.01); A61K 38/26 (2013.01); A61P 3/04 (2018.01); A61P 21/00 (2018.01); A61P 21/06 (2018.01);

Abstract

The present invention relates to the field of treatment for body composition changes in weight management. In some embodiments, the present invention provides compositions and methods for mitigating the adverse effects of treatment by weight loss drugs that suppress appetite including incretin agonist or antagonist containing drugs such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) or by sodium-glucose transport protein 2 (SGLT-2) inhibitors. In one embodiment, the present invention provides a composition of semaglutide and a selective androgen receptor modulator (SARM) compound of Formula IX.

Find Patent Forward Citations